New Referral Pathway Cuts Palliative Radiotherapy Wait

Share this content:
New Referral Pathway Cuts Palliative Radiotherapy Wait
New Referral Pathway Cuts Palliative Radiotherapy Wait

WEDNESDAY, Sept. 6, 2017 (HealthDay News) -- Use of an advanced practice radiation therapist (APRT) may help reduce radiotherapy waiting times for palliative patients, according to a study published Aug. 29 in the Journal of Medical Radiation Sciences.

Mary Job, from Princess Alexandra Hospital in Australia, and colleagues assessed patient demographics and time in working days from referral to treatment for consecutive palliative patients. Comparisons were made between 48 patients referred via a new referral pathway (NP) that sent them directly to an APRT and 102 patients referred via the standard referral pathway (SP).

The researchers found that there was a significant reduction in the number of days from referral to treatment for patients referred through the NP. Patients referred through the NP via the palliative APRT had a mean wait time of 3.5 days and a median wait time of three days versus 8.1 and five days, respectively, for patients referred through the SP. Patients referred via NP were also more likely to have the treatment completed with fewer visits to the hospital.

"The new referral pathway utilizing a dedicated palliative APRT decreased waiting times for patients receiving palliative radiotherapy and improved timely access to the radiotherapy service for both referrers and patients," conclude the authors.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »